ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AGL Angle Plc

17.75
4.00 (29.09%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Angle Plc LSE:AGL London Ordinary Share GB0034330679 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  4.00 29.09% 17.75 17.00 18.50 18.25 15.25 16.25 7,554,983 16:29:58
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Business Services, Nec 1.04M -21.69M -0.0832 -2.13 46.25M

Angle PLC Edison issues research update on Angle

27/05/2016 3:12pm

RNS Non-Regulatory


TIDMAGL

Angle PLC

27 May 2016

London, UK, 27 May 2016

Edison issues research update on Angle

Angle has raised GBP9.6m (net) via a private placing. This supports Angle's focus on commercialising Parsortix, with the funds being applied to a range of clinical studies to demonstrate utility of the Parsortix system. Additionally, Angle announced that Cancer Research UK Manchester Institute is adopting Parsortix for routine research use, which will provide recurring sales. FY16 results in July will provide a trading update and more details on the R&D expansion strategy, likely to be scaled up with the benefit of the fund raising.

We will review our forecasts and valuation after the FY16 results in July. We see the private placement as a first step towards initiating clinical trials with new indications, giving scope for future valuation uplift (albeit diluted by the new shares for now).

Click here to view the full report

All reports published by Edison are available to download free of charge from its website: www.edisoninvestmentresearch.com

About Edison: Edison is an international equity research firm with a team of over 110 analysts, investment and roadshow professionals and works with both large and smaller capitalised companies, blue chip institutional investors, wealth managers, private equity and corporate finance houses to support their capital markets activity. Edison provides services to more than 420 retained corporate and investor clients from offices in London, New York, Frankfurt, Sydney and Wellington. Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

Contact details: Learn more at www.edisongroup.com and connect with Edison on:

 
 LinkedIn   www.linkedin.com/company/edison-investment-research 
---------  ---------------------------------------------------- 
 Twitter    www.twitter.com/Edison_Inv_Res 
---------  ---------------------------------------------------- 
 YouTube    www.youtube.com/edisonitv 
---------  ---------------------------------------------------- 
 Google+    https://plus.google.com/105425025202328783163/posts 
---------  ---------------------------------------------------- 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

NRAGMGZKDNRGVZM

(END) Dow Jones Newswires

May 27, 2016 10:12 ET (14:12 GMT)

1 Year Angle Chart

1 Year Angle Chart

1 Month Angle Chart

1 Month Angle Chart

Your Recent History

Delayed Upgrade Clock